BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28433101)

  • 1. Wilson disease - currently used anticopper therapy.
    Członkowska A; Litwin T
    Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
    Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of Wilson's disease.
    Subramanian I; Vanek ZF; Bronstein JM
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilson disease.
    El-Youssef M
    Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
    Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
    Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
    J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition, diagnosis, and management of Wilson's disease.
    Brewer GJ
    Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
    Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
    J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
    Leung M; Wu Lanzafame J; Medici V
    J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
    [No Abstract]   [Full Text] [Related]  

  • 14. [Wilson disease in 2003].
    Szalay F
    Orv Hetil; 2003 Dec; 144(50):2451-8. PubMed ID: 15067983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease: clinical, genetic and pharmacological findings.
    Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
    Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
    Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wilsons disease].
    Mareček Z; Brůha R
    Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    Brewer GJ
    CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilson disease.
    Członkowska A; Litwin T; Dusek P; Ferenci P; Lutsenko S; Medici V; Rybakowski JK; Weiss KH; Schilsky ML
    Nat Rev Dis Primers; 2018 Sep; 4(1):21. PubMed ID: 30190489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.